8 March 2023
23 January 2023
READ MOREAkston Biosciences Strengthens Board with Addition of John T. Preston
1 November 2022
READ MOREAkston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial
9 August 2022
READ MOREAkston Biosciences Receives U.S. Patent for Once-A-Week Human Insulin
9 February 2021
READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC
12 April 2021
READ MOREAkston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine
9 February 2021
READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC
5 January 2021
READ MOREAkston and LakePharma Announce Strategic Partnership to Manufacture AKS-452
22 July 2020
READ MOREAkston Biosciences Receives $2.5M Milestone Payment
27 May 2020